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History of endoscopic submucosal dissection and role for colorectal endoscopic
submucosal dissection: A Japanese perspective
Masakatsu Fukuzawa*, Takuji Gotoda
a b s t r a c t
Endoscopic resection of early gastric cancer is a well-established standard therapy in Japan, and is increasingly used in other countries. The development
of endoscopic submucosal dissection (ESD) for early gastric cancer provides en bloc R0 specimen, regardless of size and/or location. On the other hand, for
many years, conventional endoscopic mucosal resection and surgery were the only available treatments for large colorectal tumors, including laterally
spreading tumors. Recently, ESD has also been increasingly applied to the colon and rectum. However, ESD has not yet been fully established as a standard
therapeutic method for colorectal lesions because of its technical difﬁculty and complications, such as perforation and longer procedure time than the
conventional endoscopic mucosal resection. In this report, we provide an overview of the indications for colorectal ESD and presented clinical outcome,
regarding the safety and efﬁcacy in our hospital with a review of the published works.
Copyright  2012, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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Endoscopic submucosal dissection (ESD) was initially developed
for the treatment of early gastric cancer to facilitate en bloc resection
of large superﬁcial tumors.1–5 The primary purpose of ESD is to
decrease the risk of local cancer recurrence, by performing en bloc
resection andproviding an accurate histopathological diagnosis. ESD
iswidely used for the treatment of carcinoma of the early gastric and
esophageal carcinoma in Japan.6–10 National health insurance covers
the expense of ESD, as a therapeutic procedure, for early gastric and
esophageal carcinoma. However, ESD has not yet been recognized as
a standard therapeutic procedure for early colorectal carcinoma
because of its technical difﬁcultywith the risk of complications, such
as perforation and bleeding and its longer procedure time. More
recently, with the development of various new instruments,11–15 the
increased effectiveness of colorectal ESD has been reported.16–25 The
number of medical facilities that perform colorectal ESD has also
been increasing recently in theWest.26–28
This review focuses on the process of development of the
upper gastrointestinal (GI) ESD, an indication for lower GI ESD,
and several differences between Japan and Western countries in
performing ESD for the lower GI lesions.
History of endoscopic treatment for GI tumors
Endoscopic resection to treat cancer is perhaps the most grati-
fying endoscopic procedure to perform because of its minimalDepartment of Gastroentelorogy and Hepatology, Tokyo Medical University, Tokyo, Japan
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gastric cancer (EGC) is a standard therapeutic choice in Japan and is
increasingly used globally.29,30 Endoscopic resection offers mini-
mally invasive treatment at a lower cost, but with comparable
efﬁcacy to surgery. It allows complete pathological staging of the
cancer, which is critical for risk stratiﬁcation of metastatic poten-
tial.31 Patients who are stratiﬁed to have no or lower risk for
developing lymph node metastasis than the risk of mortality from
surgery are ideal candidates for endoscopic resection.32
The ﬁrst endoscopic resection of early cancer was reported in
colorectal polypectomy,usinghigh-frequencyelectric surgicalunit. 33
Indeed, the ﬁrst endoscopic polypectomy used to treat pedunculated
or semipedunculated EGC was ﬁrst described in Japan, during the
year 1974. The “strip biopsy” technique, an early method of endo-
scopicmucosal resection (EMR) technique, was devised in 1984 as an
application of endoscopic snare polypectomy.34 For this method,
a double channel endoscope is used in order to snare the early cancer,
while it is being pulled toward the endoscope with a grasper. The
technique was designed for resection of small lesions with
a surrounding normal margin, thus allowing a proper pathological
assessment. To ensure that the snare captures the entire lesion with
a 5-mm surrounding normal margin, in 1988, a technique called
ERHSE (endoscopic resectionwith local injection of hypertonic saline
epinephrine solution) was developed by Hirao and colleagues.35 The
technique is composed of performing a snare resection of a cancer
with a normal margin,35 which has been isolated with normal
surrounding mucosa, by circumferential incision into theical University, 6-7-1 Nishishinjuku, Shinjukuku, Tokyo 160-0023, Japan.
on. Published by Elsevier. All rights reserved.
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after injection of hypertonic saline and diluted epinephrine, the
periphery of the lesion was incised using a needle knife, and the
lesion was removed using a snare. Unfortunately, this rather
amazing technique required considerable skills to performgiven the
risks of perforation from using the needle knife.
EMR with cap-ﬁtted panendoscope method (EMRC) was
developed in 1992 for the resection of early esophageal cancer and
directly applicable for the resection of EGC.36 The technique uses
a transparent plastic cap, which is mounted to the tip of a standard
endoscope. A specialized snare is prelooped inside the groove of
the inner aspect in the distal part of the cap, thus allowing its use to
cut the lesions that are suctioned into the cap. The EMR technique
using ligation, which was subsequently extended to EMR using
multiband ligation (EMR-L/EMR-MBL), utilizes band ligation to
create a “pseudopolyp” by suctioning the lesion into the banding
cap and deploying a band underneath it.37,38 The EMRC and EMR-L/
EMR-MBL technique have the advantage of being relatively simple.
These techniques require the use of a standard endoscope, without
any additional equipment or assistant. However, these techniques
cannot be used to remove the lesions en bloc larger than 2 cm.39,40
Piecemeal resections in lesions larger than 2 cm leads to a high risk
for local cancer recurrence and inadequate pathological staging.41
Therefore, methods to remove large lesions en bloc were
developed.42
Development of ESD for EGC
The Insulated-tip diathermic knife (IT-knife) was devised in late
1990s at the National Cancer Center Hospital Japan, in order to
resolve the problems observed during the EMR and ERHSE tech-
niques for the resection of EGC. The knife has a ceramic ball tip, thus
preventing it from puncturing the wall during the application of
cautery and causing perforation. The knife can also be used to
dissect the submucosa, which leads to the name of the techni-
quedESD technique.1,3,11 Subsequent studies have proven that ESD,
using a standard single-channel endoscope, can be used for the
resection of large lesions en bloc, allowing for a precise pathological
staging.
With the development of ESD, the indication criteria for endo-
scopic resection were revised. The empirical indications for EMR
were therefore: (1) papillary or tubular (differentiated) adenocar-
cinoma, (2) less than 2 cm in diameter, (3) without ulceration
within tumor, and (4) no lymphatics or vessels involvement.43
Clinical observations have noted that the empirical indications for
EMR are too strict and lead to unnecessary surgery. Therefore,
expanded criteria for endoscopic resection have been proposed,
especially after large en bloc resection could be accomplished using
ESD.44,45 Long-term survival and outcomes studies also showed
that ESD patients who have the treatment following the expanded
criteria are similar to those who have the treatment following the
guideline criteria.46 Other ESD knives6–10 and techniques have
since been developed and studied in detail. Within less than
a decade, ESD has become the standard of treatment for resection
of EGC in Japan.
Conventional EMR for lower GI tumors
Recently, ESD has also been increasingly applied to the colon
and rectum (Fig. 1A–D). Many studies by Japanese endoscopists
have reported that colorectal ESD can overcome the technical
limitation of EMR and achieve higher en bloc resection rate16–23
with the development of various new devices.11–14 However, this
procedure is known to have several disadvantages compared to
conventional colorectal EMR: greater technical difﬁculty, longerprocedure time, and increased risk of complications, including
perforation and bleeding.
EMR is indicated for the treatment of superﬁcial, early-stage
colorectal cancer because of its minimal invasiveness and excel-
lent results in terms of clinical outcomes.33,47 However, conven-
tional EMR techniques currently used for the resection of laterally
spreading tumors (LSTs)48–51 are inadequate for the en bloc resec-
tion of ﬂat lesions 20 mm because of incomplete removal and
problems with local recurrence.52 Conventional EMRs usually
resulted in endoscopic piecemeal mucosal resection (EPMR),
particularly for large LSTs 20 mmwith reports of local recurrence
rates, ranging from 7.4% to 17%.49,52,53 Most of those recurrences,
however, received repeated endoscopic treatment with excellent
results in terms of the preservation of the colorectum. But only
a few cases required surgery after EPMRs in the long-term follow-
up study.20 Those cases may originally have had either submucosal
invasion or lymphatic invasion that was not diagnosed histologi-
cally because of the increased difﬁculty in assessing a piecemeal
resection.
Indications for lower GI ESD
Colonic LSTs are good candidates for endoscopic treatment,
because they extend laterally rather than vertically. Based on clin-
icopathological analysis of LSTs, LST nongranular type (LST-NG) has
a higher rate of submucosal invasion, and diagnosis of tumor depth
is more difﬁcult to make endoscopically compared to LST granular
type (LST-G).51 LST-G showing adenoma or focal cancer in adenoma
is an indication for EPMR under the condition that the cancerous
portion is perfectly resected en bloc. Observation of the pit
pattern54–56 with a magnifying endoscope is essential before
piecemeal EMR. Endoscopic treatment is indicated for the adenoma
and intramucosal or submucosal superﬁcial (sm1: less than
1000 mm from the muscularis mucosae) colorectal cancer because
of its minimal invasiveness and negligible risk of lymph-node
metastasis.57
In our hospital, we performed preoperative endoscopy and
examined the lesion under magnifying chromoendoscopy for all
cases. Then, we diagnosed the depth of the lesion and determined
themost appropriate procedure. An invasive patternwas considered
a contraindication for ESD.55,56 The existence of a noninvasive
pattern, as determined bymagniﬁcation chromoendoscopy, was the
minimum requirement for all lesions that were candidates for ESD
and EMR. When a lesion was detected by conventional endoscopic
examination, surface mucous was washed away with lukewarm
water that contained pronase (Pronase MS; Kaken Pharmaceutical
Co., Ltd., Tokyo, Japan), and then 0.4% indigo-carmine dye was
sprayed over the lesion to enhance its surface detail. High-
magniﬁcation colonoscopes (CF-H260AZI, CF-FH260AZI, and PCF-
Q260AZI; Olympus Optical Co., Ltd., Tokyo, Japan) were used to
evaluate the surface character to differentiate an invasive pattern
from a noninvasive pattern. The invasive pattern is characterized by
irregular and distorted epithelial crests, observed in a demarcated
area, suggesting that sm invasion is >1000 mm, while a noninvasive
pattern does not have this ﬁnding, which suggests intramucosal
neoplasia or sm invasion <1000 mm. When high-magniﬁcation
observation with indigo-carmine dye was insufﬁcient to deter-
mine the surface structure, we performed staining with 0.05%
crystal violet. Based on extensive clinicopathological analyses, we
deﬁned the indications for ESD.
In our institution, the indications for colorectal ESD are lesion
size more than 20 mm for LST-NG or more than 30 mm for LST-G.
An LST-G 20–30 mm can be treated by planned EPMR, rather
than ESD with the area, including the largest nodule resected ﬁrst
followed by the remaining tumor. Mucosal lesions with
Fig. 1. Endoscopic submucosal dissection for a 30 mm laterally spreading tumor nongranular (LST-NG) type with scar after endoscopic mucosal resection located in the transverse
colon. (A-1) Conventional colonoscopy image. (A-2) Conventional colonoscopy image following 0.4% indigo-carmine dye spraying. (B) Magniﬁed view revealing a non-invasive
pattern. (C-1) An injection solution was injected into the submucosal layer to lift the lesion. (C-2) Submucosal layer with ﬁbrosis. (C-3) After ESD view. (D-1) Histological
image, in the part of black box is submucosal invasion (HE staining). (D-2) Histological diagnosis; well-differentiated adenocarcinoma (tub1), pSM (50 mm), ly0, v0, pHM0, pVM0.
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Table 1 Indication of Endoscopic Submucosal Dissection (ESD) for Colorectal
Tumor by Colorectal ESD Standardization Implementation Working Group
1. Large sized (>20 mm in diameter) lesions in which en bloc
resectiom using snare EMR is difﬁcult, although it is indicative
for endoscopic treatment
LST-NG,particularly those of the pseudo-depressed type
Lesions showing VI type pit pattern in kudo’s classiﬁcation
Carcinoma with submucosal inﬁltration
Large depressed type lesion
Large elevated lesion suspected to be carcinoma
2. Mucosal lesions with ﬁbrosis caused by prolapse due to biopsy or peristalsis of
the lesions
3. Sporadic localized tumors in chronic inﬂammation such as
ulcerative colitis
4. Local residual early carcinoma after endoscopic resection
Including granular-type laterally spreading tumors (LST-G), nodular mixed type.
EMR, endoscopic mucosal resection.
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adenoma or early carcinoma after endoscopic resection, which is
difﬁcult to resect by conventional EMRdwere considered appro-
priate for colorectal ESD. Similar indications for colorectal ESD,
recommended by the Colorectal ESD Standardization Imple-
mentation Working Group, are as follows (Table 1)58: (1) lesions
difﬁcult to remove en bloc with a snare EMR due to size, such as
nongranular LST (particularly pseudo-depressed type), lesions
showing a type Vi pit pattern in Kudo’s classiﬁcation and
protruded-type large lesions suspected to be carcinoma; (2) lesions
with ﬁbrosis due to biopsy or peristalsis; (3) sporadic localized
lesions in chronic inﬂammation, such as ulcerative colitis; and (4)
local residual carcinoma after EMR. However, ESD for lesions with
severe ﬁbrosis is technically very difﬁcult. To select the best therapy
(piecemeal EMR, ESD, or surgical resection) in practice, we should
consider not only the clinicopathological features of the lesions and
location, but also the skill level of the colonoscopist, including the
ability in scope handling and the predicted procedure time.
In April 2012, colorectal ESD for the lower GI neoplasm
(adenoma/cancer) was recognized as a clinical practice provided by
the Japanese national health insurance. The indications for colo-
rectal ESD under this system are deﬁned as colorectal adenoma/
early colorectal carcinoma of more than 20 mm and less than
50 mm, which are difﬁcult to resect en bloc by conventional EMR.
Lower GI ESD procedure
The primary purpose of ESD is to decrease the risk of local
cancer recurrence by performing en bloc R0 resection and to
provide a complete pathological specimen. ESD techniques areFig. 2. ESD forceps (A) B-knife (XEMEXavailable using various knives.11–15 A standard single channel
gastroscope is usually used for ESD. When the lesions are located at
the rectum or proximal colon, Q260J endoscope (Olympus Optical)
is mostly used. For the lesions located at the distal colon, PCF-
Q260JI endoscope (Olympus Optical) is used. Injection solutions
are glycerol and sodium hyaluronate with small amounts of indigo
carmine. Indigo carmine is added to the submucosal injection ﬂuid
in order to make a better identiﬁable blue-colored submucosal
layer. It has been recently reported that the use of sodium hyalur-
onate (MucoUp; Johnson & Johnson, Tokyo, Japan) for submucosal
injection provides a longer-lasting submucosal cushion, helping to
prevent perforation and make the ESD procedures technically
easier and safer.59 After the submucosal injection, a circumferential
incision in the mucosa was made with cutting devices at ﬁrst. The
procedures were primarily performed using a bipolar needle knife
(B- knife) (XEMEX Co., Tokyo, Japan)or a monopolar knife (Dual
knife, IT knife-2) (Olympus Co., Tokyo, Japan) in our hospital
(Fig. 2A, B). The B-Knife were usedwith the following setting; 50W,
effect 3, Endo-Cut mode, and 30 W, effect 3, Forced coagulation
mode with ICC200. The Dual Knife were used with the following
setting: 30 W, effect 3, EndoCut mode, and 30 W, effect 3, Forced
coagulationmodewith ICC200. Injection solutionwas then injected
into the submucosal layer to lift the lesion, and the thickened
submucosal layer was cut with the same knives. Attachment hood
is used in all procedures. A soft transparent hood (JMDN 38819001;
Top Corp., Tokyo, Japan) is mounted at the distal end of the
gastroscope in order to optimize the visualization of the operating
ﬁeld in the submucosal space and to create countertraction for
exfoliating the submucosal tissue. A small-caliber-tip transparent
hood (ST hood; Fujiﬁlm Co., Ltd., Tokyo, Japan) is also useful to lift
the incised submucosal tissue and stabilize the submucosal
dissection.60 Conscious sedation by intravenous injection of mid-
azolam (2 mg) was used before the insertion of colonoscope. In
addition, 2 mg was given repeatedly, based on the endoscopist’s
judgment. In all cases, we used a high-frequency generator unit
ICC200 (Erbe Elejtromedizim, Tübingen, Germany) and a carbon
dioxide (CO2) insufﬂation system, which is essential for reducing
abdominal discomfort.61,62
Clinical outcome of lower GI ESD
We searched PubMed database for publications until July 2012,
related to colorectal ESD, using the key words, ESD and colon. The
MEDLINE database was also used to search for publications through
July 2012 related to ESD, using the above-mentioned keywords. A
manual searchof the citationsof relevant articleswas also performed.Co.). (B) Dual knife (Olympus Co.).
Table 2 A Clinical Outcome of Colorectal Endoscopic Submucosal Dissection (ESD) in Large Series (>100) from Previous Reports and in Our Hospital
Authors (y) No.
of cases
Size
(mm)
En bloc resection
rate (%)
Complete en bloc
resection rate (%)
Complication Local
recurrence(%)
Perforation (%) Bleeding (%)
Isomoto (2009)17 292 26.8 263/292 (90.1%) 233/292 (79.8%) 23/292 (8.2%) 2/292 (0.7%) 1/220 (0.5%)
Saito (2009)18 405 40 352/405 (87%) – 14/405 (3.5%) 4/405 (1.0%) –
Hotta (2010)19 120 35 112/120 (93.3%) 102/120 (85%) 9/120 (7.5%) – –
Niimi (2010)20 310 28.9 280/310 (90.3%) 231/310 (74.5%) 15/310 (4.8%) 5/310 (1.6%) 4/202 (2.0%)
Yoshida (2010)21 250 29.1 217/250 (86.8%) 203/250 (81.2%) 15/250 (6%) 6/250 (2.4%) –
Toyonaga (2010)22 512 29 503/512 (98.2%) – 9/512 (1.8%) 8/512 (1.6%) –
Matsumoto (2010)23 203 32.4 – 174/203 (85.7%) 14/203 (6.9%) – –
Uraoka (2011)24 202 39.9 185/202 (91.6%) – 5/202 (2.5%) 1/202 (0.5%) 0/165 (0%)
Hisabe (2012)25 200 32.7 172/200 (86%) – 14/200 (7.0%) 2/200 (1.0%) –
Fukuzawa (2012) 200 34.6 180/200 (90%) 172/200 (86%) 4/200 (2%) 3/200 (1.5%) 4/200 (2%)
Gastrointestinal Intervention 2012 1(1), 30–3534Pertinent studies published in English and Japanesewere reviewed. If
an institution had published several reports on colorectal ESD, the
newest reportwasselected for the summaryofoutcomesof colorectal
ESD. A clinical outcome of colorectal ESD in large series (>100) about
the previous reports and our hospital is described in Table 2.
Regardingefﬁcacy, theenbloc resection (endoscopic) andcomplete en
bloc resection (histological) rates were 90.1% (86–98.2%, 2264/2491)
and 81.1% (74.5–86%, 1115/1375), respectively. Regarding complica-
tions, theperforationand latebleeding rateswere4.5% (1.8–8.2%,122/
2694) and1.3% (0.5–2.4%, 31/2371), respectively. Local recurrencewas
detected in 1.1% (0–2%, 9/768) of cases.
Lower GI ESD in Western countries
Several reports were published from Western countries con-
cerning colorectal ESD26–28; however, compared to Japan it is
infrequently performed inWestern countries. Uraoka et al reported
that there are several differences between practices in Japan and
Western countries. At ﬁrst, according to the measurement of
colonic length of Asian and Caucasian patients, the colonic length of
Caucasian patients was signiﬁcantly longer.63 In the clinical setting,
short-type (1.3 m) colonoscopes are regularly used in Japan,
whereas in most Western countries, long (1.7 m) colonoscopies are
used. Therefore, a more difﬁcult colonic anatomy and the frequent
need for longer colonoscopes would support the possibility that
colonoscopy and related therapeutic procedures are more complex
in Western patients. Second, Western endoscopists prefer to use
propofol for sedation during colonoscopy. If the position of the
patient is not going to be changed during colonoscopy, then
stronger sedation can be used. However, taking advantage of
gravitation during colonoscopy is useful, as the submucosal
dissection plane can be observed more clearly in certain patient
positions, in which the partially dissected lesion is pulled down by
its own weight. Patient rotation can be used by Japanese endo-
scopists during colorectal ESD, because they do not apply deep
sedation to their patients. One of the main limitations to the
implementation of ESD in Western countries is that, compared to
Japan, there are very few institutions with enough expertise in
colorectal ESD to become training centers. However, in Japan,
a signiﬁcant number of endoscopists have experience, at
a minimum, in more than 50 colorectal ESD cases.64 Furthermore,
development of various devices, specialized in each part of the
digestive tract, was regarded as the major factor why the ESD
procedure is widely practiced in Japan. Performing ESD in a clinical
setting with appropriate professional guidance and supervision
also is an important consideration in terms of the learning curve, at
least in the early phases of actual clinical experience.
In the future, establishment of a training system for colorectal
ESD, based on clinical outcomes and the learning curves for
trainees,19,65 is necessary to standardize training and achieve
wider acceptance of the technique.66Disclosure
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